INTRODUCTION: Chronic thromboembolic pulmonary hypertension (CTEPH) and venous thromboembolism (VTE) are thought to share many common risk factors. Our study aimed to determine the frequencies of 5 thrombosis-related gene single nucleotide polymorphisms (SNPs) associated with VTE in patients with CTEPH (n 129) compared with a control group of healthy individuals without a history of VTE (n 2637). METHODS: The SNPs of the following genes were investigated: F5 (F V Leiden, rs6025), F2 prothrombin (rs1799963), fibrinogen gamma (FGG, rs2066865), F11 (rs2289252) and ABO (non-O, rs8176719) in both groups. RESULTS: The study found that the rs1799963 variant was more common in patients with chronic thromboembolic pulmonary hypertension (CTEPH) compared to the control group (p < .0001). The GA heterozygous variant showed a significant increase with an odds ratio (OR) of 4.480 (95% CI: 2.344-8.562) or a finding by maximum likelihood analysis (MLA) with p < .0001. Additionally, there was a notable increase in the rs8176719 variant with p < .0001 in CTEPH patients. Both the homozygous G/G variant and the heterozygous -/G variant also showed an increase, with OR of 4.2317 (95% CI: 2.45571-7.2919) and 2.4324 (95% CI: 1.46435-4.0403) respectively, or MLA (p < .0001 and p .0006). The study also revealed a higher prevalence of the heterozygous C/T variant of rs2289252 in CTEPH patients, with an OR of 1.5543 (95% CI: 1.02503-2.3568) or MLA (p .0379). CONCLUSION: The study suggests that the observed gene polymorphisms F2 (rs1799963), ABO (rs8176719), and F11 (rs2289252) may play a role as independent heritable risk factors in the development of CTEPH.

1st Department of Medicine Division of Haematology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

2nd Department of Medicine Division of Cardiovascular Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Centre for Cardiovascular Prevention 1st Faculty of Medicine Charles University and Thomayer University Hospital Prague Czech Republic

Department of Blood Transfusion 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Thrombotic Centre Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

See more in PubMed

Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J. 2020;41(4):543-603. PubMed

Delcroix M, Torbicki A, Gopalan D, et al. ERS Statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021;57(6):2002828. PubMed

Jansa P, Ambrož D, Kuhn M, et al. Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic. Pulm Circ. 2022;12(1):e12038. PubMed PMC

Kerr KM, Elliott CG, Chin K, et al. Results from the United States chronic thromboembolic pulmonary hypertension registry: Enrollment characteristics and 1-year follow-up. Chest. 2021;160(5):1822-1831. PubMed PMC

Humbert MS, Simonneau G, Pittrow D, et al. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2022;41(6):716-721. PubMed

Rosendaal F. Venous thrombosis: A multicausal disease. Lancet. 1999;353(9159):1167-1173. PubMed

Margaglione M, Grandone E. Population genetics of venous thromboembolism. A narrative review. Thromb Haemost. 2011;105(2):221-231. PubMed

Zöller B, Li X, Ohlsson H, et al. Family history of venous thromboembolism as a risk factor and genetic research tool. Thromb Haemost. 2015;114(5):890-900. PubMed

Bezemer ID, Bare LA, Doggen CJ, et al. Gene variants associated with deep vein thrombosis. JAMA. 2008;299(11):1306-1314. PubMed

Trégouët DA, Heath S, Saut N, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: Results from a GWAS approach. Blood. 2009;113(21):5298-5303. PubMed

Lindström S, Wang L, Smith EN, et al. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood. 2019;134(19):1645-1657. PubMed PMC

Klarin D, Busenkell E, Judy R, et al. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease. Nat Genet. 2019;51(11):1574-1579. PubMed PMC

Thibord F, Klarin D, Brody JA, et al. Cross-Ancestry investigation of venous thromboembolism genomic predictors. Circulation. 2022;146(16):1225-1242. PubMed PMC

Tang W, Teichert M, Chasman DI, et al. A genome-wide association study for venous thromboembolism: The extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet Epidemiol. 2013;37(5):512-521. PubMed PMC

Kvasnička T, Hájková J, Bobčíková P, et al. The frequencies of six important thrombophilic mutations in a population of the Czech Republic. Physiol Res. 2014;63(2):245-253. PubMed

Cífková R, Bruthans J, Wohlfahrt P, et al. 30-year Trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985 - 2016/17. PLoS One. 2020;15(5):e0232845. PubMed PMC

de Haan HG, Bezemer ID, Doggen CJ, et al. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood. 2012;120(3):656-663. PubMed

van Hylckama Vlieg A, Flinterman LE, Bare LA, et al. Genetic variations associated with recurrent venous thrombosis. Circ Cardiovasc Genet. 2014;7(6):806-813. PubMed

Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-67. PubMed

Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry. Circulation. 2011;124(18):1973-1981. PubMed

Lang IM, Klepetko W, Pabinger I. No increased prevalence of the factor V Leiden mutation in chronic major vessel thromboembolic pulmonary hypertension (CTEPH). Thromb Haemost. 1996;76(3):476-477. PubMed

Wolf M, Boyer-Neumann C, Parent F, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000;15(2):395-399. PubMed

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP working group: Routine testing for factor V Leiden (R506Q) and prothrombin (20210G > A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med. 2011;13(1):67-76. PubMed

Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88(10):3698-3703. PubMed

Colorio CC, Martinuzzo ME, Forastiero RR, et al. Thrombophilic factors in chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis. 2000;12(6):427-432. PubMed

Suntharalingam J, Goldsmith K, van Marion V, et al. Fibrinogen A alpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J. 2008;31(4):736-741. PubMed

Lussana F, de Rooij SR, Veenendaal Met al. Prevalence of factor V Leiden and G20210A prothrombin mutation in the Dutch famine birth cohort: A possible survival advantage? Tromb Haemost. 2012;108(02):399-401. PubMed

Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, et al. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma’ levels. Blood. 2005;106(13):4176-4183. PubMed

Uitte de Willige S, Rietveld IM, De Visser MC, et al. Polymorphism 10034 C > T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio. J Thromb Haemost. 2007;5(6):1243-1249. PubMed

Uitte de Willige S, Standeven KF, Philippou H, et al. The pleiotropic role of the fibrinogen gamma’ chain in hemostasis. Blood. 2009;114(19):3994-4001. PubMed

Jiang J, Liu K, Zou J, et al. Associations between polymorphisms in coagulation-related genes and venous thromboembolism: A meta-analysis with trial sequential analysis. Medicine (Baltimore). 2017;96(13):e6537. Erratum in: Medicine (Baltimore). 2017; 96 (23): e7233. PubMed PMC

Li Y, Bezemer ID, Rowland CM, et al. Genetic variants associated with deep vein thrombosis: The F11 locus. J Thromb Haemost. 2009;7(11):1802-1808. PubMed

Lunghi B, Cini M, Legnani C, et al. The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis. Thromb Res. 2012;130(3):563-564. PubMed

Yamamoto F, Clausen H, White T, et al. Molecular genetic basis of the histoblood group ABO system. Nature. 1990;345(6272):229-233. PubMed

Ibrahim-Kosta M, Bailly P, Silvy M, et al. ABO Blood group, glycosyltransferase activity and risk of venous thromboembolism. Thromb Res. 2020;193:31-35. PubMed

Bonderman D, Wilkens H, Wakounig S, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33(2):325-331. PubMed

Sabater-Lleal M, Huffman JE, de Vries PS, et al. Genome-Wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von willebrand factor plasma levels. Circulation. 2019;139(5):620-635. PubMed PMC

Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003;90(3):372-376. PubMed

Newnham M, South K, Bleda M, et al. The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(3):1801805. PubMed PMC

The Prevalence of the Thrombotic SNPs rs6025, rs1799963, rs2066865, rs2289252 and rs8176719 in Patients with Venous Thromboembolism in the Czech Population